ATE381577T1 - Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma - Google Patents

Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma

Info

Publication number
ATE381577T1
ATE381577T1 AT97935986T AT97935986T ATE381577T1 AT E381577 T1 ATE381577 T1 AT E381577T1 AT 97935986 T AT97935986 T AT 97935986T AT 97935986 T AT97935986 T AT 97935986T AT E381577 T1 ATE381577 T1 AT E381577T1
Authority
AT
Austria
Prior art keywords
apolipoprotein
apoe
apoa
human plasma
atherosclerosis
Prior art date
Application number
AT97935986T
Other languages
English (en)
Inventor
Stefan Winge
Sara Wiklund
Original Assignee
Esperion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9603068A external-priority patent/SE9603068D0/xx
Application filed by Esperion Therapeutics Inc filed Critical Esperion Therapeutics Inc
Application granted granted Critical
Publication of ATE381577T1 publication Critical patent/ATE381577T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97935986T 1996-08-23 1997-08-22 Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma ATE381577T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603068A SE9603068D0 (sv) 1996-08-23 1996-08-23 Process for purifying a protein
US2538796P 1996-09-04 1996-09-04

Publications (1)

Publication Number Publication Date
ATE381577T1 true ATE381577T1 (de) 2008-01-15

Family

ID=26662734

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935986T ATE381577T1 (de) 1996-08-23 1997-08-22 Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma

Country Status (7)

Country Link
EP (1) EP0934337B1 (de)
JP (1) JP2001522349A (de)
AT (1) ATE381577T1 (de)
AU (1) AU731021B2 (de)
CA (1) CA2274241C (de)
DE (1) DE69738397D1 (de)
WO (1) WO1998007751A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306433B1 (en) 1997-08-12 2001-10-23 Pharmacia Ab Method of preparing pharmaceutical compositions
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
DE19963420A1 (de) * 1999-12-28 2001-07-12 Sebo Gmbh Gewinnung von biologischen Komponenten aus Körperflüssigkeiten
BR0108924A (pt) * 2000-03-03 2003-04-29 Smithkline Beecham Biolog Composição umonogênica adaptada para administração a um hospedeiro humano para o tratamento ou prevenção da aterosclerose, vacina, e, método de tratamento ou profilaxia da aterosclerose
CN103408658A (zh) 2007-08-17 2013-11-27 Csl百灵有限公司 α-1-抗胰蛋白酶和载脂蛋白A-I的纯化方法
CN102123737B (zh) 2008-06-13 2014-01-01 西马生物医学计划公司 用于生物活性化合物施用的轭合物
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
MX2015016670A (es) * 2013-06-05 2016-07-15 Csl Ltd Proceso para preparar apolipoproteina a-i (apo- a-i).
CN107033237B (zh) * 2017-05-11 2021-07-20 深圳市卫光生物制品股份有限公司 一种人血浆载脂蛋白a-i的分离纯化方法
CN110590937A (zh) * 2018-06-13 2019-12-20 杨宝田 一种人血载脂蛋白a1制品的制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum

Also Published As

Publication number Publication date
JP2001522349A (ja) 2001-11-13
CA2274241A1 (en) 1998-02-26
EP0934337A1 (de) 1999-08-11
CA2274241C (en) 2003-05-27
DE69738397D1 (de) 2008-01-31
EP0934337B1 (de) 2007-12-19
AU731021B2 (en) 2001-03-22
AU3876297A (en) 1998-03-06
WO1998007751A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
SE9603068D0 (sv) Process for purifying a protein
UA66745C2 (en) INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES
DE69629949D1 (de) Aktivierte verbindungen und verfahren zur herstellung und reiningung
DE69508859D1 (de) Verfahren zur Reinigung von (-)-n-Isopulegol sowie gereinigtes (-)-n-Isopulegol enthaltende Zitrusparfümzusammensetzungen
ATE200293T1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
DE69636096D1 (de) Verfahren zur behandlung von gefässrestenose durch inhalieren von stickoxid
ATE225368T1 (de) Verfahren zur reinigung von faktor viii
DE69632887D1 (de) Verfahren zur zweckmässige Herstellung von Transglutaminase durch DNA-Rekombination
DK1003546T3 (da) Fremgangsmåde til behandling af patienter ramt af dissemineret sklerose ved anvendelse af konsensus interferon
ATE381577T1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
DE68900949D1 (de) Verfahren zur trennung von wasserstoffbehandlungs-ausfluessen.
ATE206158T1 (de) Verfahren zur herstellung von gereinigtem enzym
ATE240743T1 (de) Verfahren und substanzen gegen protozoen
SE9603303D0 (sv) Process for purifying a protein
ATE179717T1 (de) Verfahren zur reinigung von menschlichem albumin
ATE347564T1 (de) Verfahren zur reinigung von hämoglobin
DE69531308D1 (de) Verfahren zur Herstellung von gereinigten papillomavirus Proteinen
ATE131490T1 (de) Verfahren zur herstellung von gereinigten albuminlösungen
DE69433243D1 (de) Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit
DE69430079D1 (de) Verfahren zur Herstellung von Oenothein-B aus Epilobium Parviflorum
SE9603304D0 (sv) Process for purifying a compound
ATE222925T1 (de) Verbessertes verfahren zur herstellung von faktor viii
DE69002903T2 (de) Verfahren zur Erniedrigung des Benzolgehaltes von Benzinen.
DE69416103D1 (de) Verdrängungschromatographisches verfahren und gereinigtes hämoglobin
DE69515206T2 (de) Verfahren zur Herstellung von Glycidylacrylat oder Glycidylmethacrylat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties